Paper II
2022 February (2019 Scheme) · 100 marks · 180 min

Question

Methotrexate

Q104 marksShort Answers

Answer

Methotrexate is a folate-antagonist antimetabolite. MOA: competitively inhibits dihydrofolate reductase, blocking tetrahydrofolate regeneration and halting purine/thymidine synthesis, arresting DNA replication (S-phase specific). Leucovorin (folinic acid) rescue allows higher doses while sparing normal host cells. Uses: acute lymphoblastic leukemia, lymphomas, choriocarcinoma; at low doses — rheumatoid arthritis, psoriasis (immunomodulatory). Adverse effects: bone marrow suppression, mucositis, hepatotoxicity, nephrotoxicity, teratogenicity.

Other Years Asked


Revise MBBS
Preview